• Ruxolitinib Phosphate: From JAK Signals to Cell Fate

  2026-08-30

  A translational perspective on how Ruxolitinib phosphate and INCB018424 can be used to connect JAK1/2 inhibition with STAT3-dependent mitochondrial remodeling, apoptosis, and pyroptosis in anaplastic thyroid carcinoma research.

• E-64d Workflows for Calpain and Cell-Death Research

  2026-08-29

  E-64d combines intracellular access with irreversible cysteine protease inhibition, making it useful for platelet, apoptosis, neuronal, and cancer research workflows. This guide pairs practical dosing and handling strategies with time-resolved assay design inspired by MEDUSA, helping researchers distinguish genuine cell death from slower growth.

• 4-Phenylbutyric Acid: ER Stress Workflow

  2026-08-28

  Build a solvent-controlled 4-PBA workflow for separating endoplasmic reticulum stress from ferroptosis in HK-2 kidney injury models. This guide translates PFOS-response data into practical treatment groups, assay timing, formulation controls, and troubleshooting decisions.

• Arrb2–6-ketoLCA Axis in Hepatic Ischemia–Reperfusion

  2026-08-28

  The reference study identifies hepatocyte Arrb2 as a regulator of liver ischemia–reperfusion injury through a metabolite-mediated pathway involving 6-ketoLCA and M2 macrophage polarization. Its combination of clinical association analysis, hepatocyte-specific mouse modeling, hypoxia–reoxygenation experiments, and metabolomics provides a useful framework for studying hepatocyte–macrophage communication in transplantation-related inflammation.

• 4-Phenylbutyric Acid in ER Stress Assays

  2026-08-27

  4-PBA provides a practical rescue strategy for testing whether ER stress drives cancer-cell death, rather than merely correlating with it. This workflow combines chemical chaperone treatment with viability, autophagy, and pathway-specific controls to improve causal interpretation.

• FOXM1 and ERα in Female Lung Adenocarcinoma

  2026-08-27

  This preprint integrates transcriptomic, survival, immune, and in vitro analyses to investigate FOXM1 in female lung adenocarcinoma (LUAD). Its proposed FOXM1–miR-204-5p–ERα network offers a mechanistic framework for biomarker discovery, while the partial validation of the ceRNA model highlights important limitations for follow-up studies.

• MK-1775: Measuring Checkpoint Abrogation

  2026-08-26

  MK-1775, a selective Wee1 kinase inhibitor, can produce growth arrest and cell killing that are not captured equally by a single viability endpoint. This guide applies a quantitative assay framework to distinguish G2 checkpoint abrogation, DNA damage response inhibition, and true cytotoxicity in cancer research.

• Entinostat (MS-275) Workflows for Cancer Research

  2026-08-26

  Entinostat (MS-275) enables selective class I HDAC probing alongside separate measurements of growth arrest and cell death. This guide turns that distinction into practical dose-response, chromatin, retinoblastoma, and translational workflows with troubleshooting built in.

• Tunicamycin: Designing Better ER Stress Assays

  2026-08-25

  Tunicamycin is a powerful N-glycosylation inhibitor, but its value depends on separating glycoprotein-processing stress from inflammatory signaling. This guide translates endothelial UPR research into better-controlled macrophage and cell-based assay designs.

• Targeted mRNA Delivery to Islet β Cells

  2026-08-25

  Enriquez et al. developed enhanced glucagon-like peptide-1-conjugated lipid nanoparticles for β cell-enriched mRNA delivery and showed functional activity in mouse and human β cell models. Delivery of PD-L1 mRNA attenuated insulitis and delayed autoimmune diabetes in NOD mice, while human xenogeneic islets provided a translational test of in vivo delivery.

• Clodronate Liposomes: In Vivo Macrophage Depletion

  2026-08-24

  Clodronate Liposomes use phagocytosis-mediated delivery to deplete macrophages in vivo and test macrophage-dependent phenotypes. The K2721 reagent supports multiple administration routes, tissue-focused experimental designs, and PBS Liposome controls.

• Ceapin-A7 for Reliable ER Stress Assays

  2026-08-24

  This scenario-based guide explains how Ceapin-A7, SKU BA3709, can help researchers isolate ATF6α-dependent effects in viability, proliferation, and cytotoxicity workflows. It covers dose design, DMSO controls, assay compatibility, interpretation, storage, and practical vendor-selection criteria.

• Ampicillin Sodium: From MIC to Infection Models

  2026-08-23

  Ampicillin sodium is a β-lactam antibiotic whose value extends beyond a single MIC result. This evidence-to-model guide connects transpeptidase inhibition, resistance-aware assay design, and responsible interpretation in bacterial infection research.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) for Assays

  2026-08-22

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines Cy5 cargo tracking with EGFP translation measurement in one capped, chemically modified reporter. The dual-readout design supports quantitative mRNA delivery and translation efficiency assays, while product specifications define handling, concentration, buffer, and storage requirements.

• AO/PI Double Staining Kit: Practical Workflow

  2026-08-22

  The AO/PI Double Staining Kit provides a rapid fluorescent readout for separating viable, apoptotic-like, and membrane-compromised cell populations in one assay. It is appropriate for fresh-cell viability and cell-death profiling, but it should not be treated as a standalone confirmation of apoptosis mechanism or as a substitute for orthogonal validation.

518 records 1/35 page Next 12345 下5页 Last page